375 related articles for article (PubMed ID: 19271083)
1. Comparison of the anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis at an arthritis center.
Attar SM; Bunting PS; Smith CD; Karsh J
Saudi Med J; 2009 Mar; 30(3):446-7. PubMed ID: 19271083
[No Abstract] [Full Text] [Related]
2. Testing for anti-cyclic citrullinated peptide antibodies: is it time to set this genie free?
Shmerling RH
Arch Intern Med; 2009 Jan; 169(1):9-14. PubMed ID: 19139318
[No Abstract] [Full Text] [Related]
3. The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis.
Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Tafaj A; Izairi R; Rexhepi B
Reumatizam; 2011; 58(1):12-4. PubMed ID: 21751570
[TBL] [Abstract][Full Text] [Related]
4. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
Yalaoui S
Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
[TBL] [Abstract][Full Text] [Related]
5. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
6. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
Ljung L; Uddhammar A; Rantapää-Dahlqvist S
Lakartidningen; 2009 Aug 5-18; 106(32-33):1964-6. PubMed ID: 19764372
[No Abstract] [Full Text] [Related]
7. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S
Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
[No Abstract] [Full Text] [Related]
8. [Anti-cyclic citrullinated peptide antibody as a serological marker for the diagnosis of rheumatoid arthritis].
Suzuki K
Nihon Rinsho; 2005 Jan; 63 Suppl 1():341-3. PubMed ID: 15799374
[No Abstract] [Full Text] [Related]
9. Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis.
Morozzi G; Bellisai F; Fioravanti A; Galeazzi M
Ann Rheum Dis; 2005 Jul; 64(7):1095-6. PubMed ID: 15958771
[No Abstract] [Full Text] [Related]
10. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
[No Abstract] [Full Text] [Related]
11. A combined diagnostic approach to rheumatoid arthritis using anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
Oommen S; Appalaraju B; Sivadarshini S;
Indian J Med Microbiol; 2011; 29(2):195-6. PubMed ID: 21654124
[No Abstract] [Full Text] [Related]
12. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
13. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
Tedesco A; D'Agostino D; Soriente I; Amato P; Piccoli R; Sabatini P
Autoimmun Rev; 2009 Jan; 8(3):233-7. PubMed ID: 18708166
[TBL] [Abstract][Full Text] [Related]
14. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
[TBL] [Abstract][Full Text] [Related]
15. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
16. [Progress in early diagnosis of rheumatoid arthritis].
Kondo H; Sakai M
Nihon Rinsho; 2005 Jan; 63 Suppl 1():289-92. PubMed ID: 15799363
[No Abstract] [Full Text] [Related]
17. Synthesis of overlapping fibrin citrullinated peptides and their use for diagnosing rheumatoid arthritis.
Pérez ML; Gómara MJ; Kasi D; Alonso A; Viñas O; Ercilla G; Sanmartí R; Haro I
Chem Biol Drug Des; 2006 Oct; 68(4):194-200. PubMed ID: 17105483
[TBL] [Abstract][Full Text] [Related]
18. Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis.
Kim DA; Jearn LH; Kim TY
J Rheumatol; 2007 Sep; 34(9):1944-5. PubMed ID: 17787055
[No Abstract] [Full Text] [Related]
19. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
20. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
